Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario.

Background Although molecular testing has become standard in managing advanced nonsquamous non-small-cell lung cancer (NSCLC), most patients undergo minimally invasive procedures, and the diagnostic tumour specimens available for testing are usually limited. A knowledge translation initiative to edu...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 24; no. 2; pp. 103 - 111
Autores principales:	Lim, C., Sekhon, H. S., Cutz, J. C., Hwang, D. M., Kamel-Reid, S., Carter, R. F., da Cunha Santos, G., Waddell, T., Binnie, M., Patel, M., Paul, N., Chung, T., Brade, A., El-Maraghi, R., Sit, C., Tsao, M. S., Leighl, N. B.
Formato:	Journal Article
Publicado:	MDPI Apr2017
Acceso en línea:	Ver este registro en EBSCOhost